Eloxx Pharmaceuticals, Inc.
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2021 | $-35.0M | $-35.1M | $89.0K | $9.2M |
| FY2022 | $-31.8M | $-31.9M | $66.0K | $3.0M |
| FY2023 | $-14.3M | $-14.3M | — | $2.0M |
| FY2024 | $-4.7M | $-4.7M | — | $541.0K |
| FY2025 | $-6.3M | $-6.3M | — | $235.0K |